Keros Therapeutics, Inc. Increase (Decrease) in Accounts Receivable
Keros Therapeutics, Inc. (KROS) reported Increase (Decrease) in Accounts Receivable of -$3.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-03
- Keros Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$400.00K.
- Keros Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$3.17M, a 121.77% decline year-over-year.
- Keros Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $75.00K, a 96.81% decline year-over-year.
- Keros Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$12.32M, a 3309.38% decline year-over-year.
- Keros Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $825.00K, a 68.26% decline from fiscal 2024.
- Keros Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $2.60M, a 1717.48% increase from fiscal 2023.
- Keros Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $143.00K.
- Keros Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$18.00M, a 200.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$3.57M 10-Q · filed 2026-08-03 | -$3.49M derived: sum of 3 quarters · filed 2026-08-03 | -$15.82M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$3.17M 10-Q · filed 2026-05-14 | -$3.09M derived: sum of 2 quarters · filed 2026-05-14 | -$15.42M derived: sum of 3 quarters · filed 2026-05-14 | -$16.89M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$12.25M derived: sum of 2 quarters · filed 2026-03-04 | -$13.72M derived: sum of 3 quarters · filed 2026-08-03 | $825.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | -$12.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$13.80M derived: sum of 2 quarters · filed 2026-08-03 | $750.00K 10-Q · filed 2025-11-05 | $3.10M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $13.07M 10-Q · filed 2026-08-03 | $15.43M derived: sum of 3 quarters · filed 2026-08-03 | $15.81M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $14.55M 10-Q · filed 2026-05-14 | $16.90M derived: sum of 2 quarters · filed 2026-05-14 | $17.29M derived: sum of 3 quarters · filed 2026-05-14 | $17.07M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.74M derived: sum of 2 quarters · filed 2026-03-04 | $2.52M derived: sum of 3 quarters · filed 2026-03-04 | $2.60M 10-K · filed 2026-03-04 |
| 2024-09-30 | $384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $162.00K derived: sum of 2 quarters · filed 2025-11-05 | $245.00K 10-Q · filed 2025-11-05 | $388.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$222.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$139.00K 10-Q · filed 2025-08-06 | $4.00K derived: sum of 3 quarters · filed 2025-08-06 | $4.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $83.00K 10-Q · filed 2025-05-06 | $226.00K derived: sum of 2 quarters · filed 2025-05-06 | $226.00K derived: sum of 3 quarters · filed 2025-05-06 | $226.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $143.00K derived: sum of 2 quarters · filed 2025-02-26 | $143.00K derived: sum of 3 quarters · filed 2025-02-26 | $143.00K 10-K · filed 2025-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | -$18.00M 10-K · filed 2025-02-26 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-06 | -$18.00M 10-Q · filed 2023-11-06 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$18.00M 10-Q · filed 2023-08-07 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | -$100.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$18.00M 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | -$100.00K derived: sum of 3 quarters · filed 2024-02-28 | $0.00 derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $17.90M derived: sum of 2 quarters · filed 2024-02-28 | $18.00M derived: sum of 3 quarters · filed 2024-02-28 | $18.00M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $100.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-09 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |